FDA official logo
GSRS logo
PFDA official logo

TOCILIZUMAB

  • UNII: I031V2H011
  • Preferred Substance Name: TOCILIZUMAB

  • 375823-41-9
  • ACTEMRA
  • ATLIZUMAB
  • BAT1806
  • BAT-1806
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 6 RECEPTOR) (HUMAN-MOUSE MONOCLONAL MRA HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL MRA .KAPPA.-CHAIN, DIMER
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 6 RECEPTOR) (HUMAN-MOUSE MONOCLONAL MRA HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL MRA .KAPPA.-CHAIN, DIMER
  • MRA
  • MSB11456
  • MSB-11456
  • R-1569
  • RG-1569
  • RHPM-1
  • RO-4877533
  • ROACTEMRA
  • TOCILIZUMAB (GENETICAL RECOMBINATION)
  • TOCILIZUMAB [EMA EPAR]
  • TOCILIZUMAB [INN]
  • TOCILIZUMAB [JAN]
  • TOCILIZUMAB [MART.]
  • TOCILIZUMAB [MI]
  • TOCILIZUMAB [PURPLE BOOK CDER]
  • TOCILIZUMAB [USAN]
  • TOCILIZUMAB [VANDF]
  • TOCILIZUMAB [WHO-DD]
  • TOCILIZUMAB BIOSIMILAR (BAT-1806)
  • TOCILIZUMAB BIOSIMILAR (MSB11456)

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.